259 related articles for article (PubMed ID: 28630120)
1. Selinexor-induced thrombocytopenia results from inhibition of thrombopoietin signaling in early megakaryopoiesis.
Machlus KR; Wu SK; Vijey P; Soussou TS; Liu ZJ; Shacham E; Unger TJ; Kashyap T; Klebanov B; Sola-Visner M; Crochiere M; Italiano JE; Landesman Y
Blood; 2017 Aug; 130(9):1132-1143. PubMed ID: 28630120
[TBL] [Abstract][Full Text] [Related]
2. Miniaturized 3D bone marrow tissue model to assess response to Thrombopoietin-receptor agonists in patients.
Di Buduo CA; Laurent PA; Zaninetti C; Lordier L; Soprano PM; Ntai A; Barozzi S; La Spada A; Biunno I; Raslova H; Bussel JB; Kaplan DL; Balduini CL; Pecci A; Balduini A
Elife; 2021 Jun; 10():. PubMed ID: 34059198
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphoma.
Kuruvilla J; Savona M; Baz R; Mau-Sorensen PM; Gabrail N; Garzon R; Stone R; Wang M; Savoie L; Martin P; Flinn I; Jacoby M; Unger TJ; Saint-Martin JR; Rashal T; Friedlander S; Carlson R; Kauffman M; Shacham S; Gutierrez M
Blood; 2017 Jun; 129(24):3175-3183. PubMed ID: 28468797
[TBL] [Abstract][Full Text] [Related]
4. Effect of thrombopoietin receptor agonists on the apoptotic profile of platelets in patients with chronic immune thrombocytopenia.
Mitchell WB; Pinheiro MP; Boulad N; Kaplan D; Edison MN; Psaila B; Karpoff M; White MJ; Josefsson EC; Kile BT; Bussel JB
Am J Hematol; 2014 Dec; 89(12):E228-34. PubMed ID: 25132654
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis and management of inherited thrombocytopenias: rationale for the use of thrombopoietin-receptor agonists.
Pecci A
Int J Hematol; 2013 Jul; 98(1):34-47. PubMed ID: 23636669
[TBL] [Abstract][Full Text] [Related]
6. The role of platelet factor 4 in radiation-induced thrombocytopenia.
Lambert MP; Xiao L; Nguyen Y; Kowalska MA; Poncz M
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1533-40. PubMed ID: 21740995
[TBL] [Abstract][Full Text] [Related]
7. The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis.
Nogami W; Yoshida H; Koizumi K; Yamada H; Abe K; Arimura A; Yamane N; Takahashi K; Yamane A; Oda A; Tanaka Y; Takemoto H; Ohnishi Y; Ikeda Y; Miyakawa Y
Haematologica; 2008 Oct; 93(10):1495-504. PubMed ID: 18728031
[TBL] [Abstract][Full Text] [Related]
8. Platelet enhancement by Carica papaya L. leaf fractions in cyclophosphamide induced thrombocytopenic rats is due to elevated expression of CD110 receptor on megakaryocytes.
Nandini C; Madhunapantula SV; Bovilla VR; Ali M; Mruthunjaya K; Santhepete MN; Jayashree K
J Ethnopharmacol; 2021 Jul; 275():114074. PubMed ID: 33831466
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a novel megakaryopoiesis enhancer, ingenol, promoting thrombopoiesis through PI3K-Akt signaling independent of thrombopoietin.
Wang L; Zhang T; Liu S; Mo Q; Jiang N; Chen Q; Yang J; Han YW; Chen JP; Huang FH; Li H; Zhou J; Luo JS; Wu JM
Pharmacol Res; 2022 Mar; 177():106096. PubMed ID: 35077844
[TBL] [Abstract][Full Text] [Related]
10. Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study.
Thein KZ; Piha-Paul SA; Tsimberidou A; Karp DD; Janku F; Zarifa A; Shah J; Milton DR; Bean S; McQuinn L; Gong J; Colen R; Carter BW; Subbiah V; Ogbonna DC; Pant S; Meric-Bernstam F; Naing A
Invest New Drugs; 2021 Oct; 39(5):1357-1365. PubMed ID: 33909232
[TBL] [Abstract][Full Text] [Related]
11. Revealing eltrombopag's promotion of human megakaryopoiesis through AKT/ERK-dependent pathway activation.
Di Buduo CA; Currao M; Pecci A; Kaplan DL; Balduini CL; Balduini A
Haematologica; 2016 Dec; 101(12):1479-1488. PubMed ID: 27515246
[TBL] [Abstract][Full Text] [Related]
12. PKC-epsilon deficiency alters progenitor cell populations in favor of megakaryopoiesis.
Kostyak JC; Liverani E; Kunapuli SP
PLoS One; 2017; 12(8):e0182867. PubMed ID: 28783756
[TBL] [Abstract][Full Text] [Related]
13. Bortezomib induces thrombocytopenia by the inhibition of proplatelet formation of megakaryocytes.
Murai K; Kowata S; Shimoyama T; Yashima-Abo A; Fujishima Y; Ito S; Ishida Y
Eur J Haematol; 2014 Oct; 93(4):290-6. PubMed ID: 24750292
[TBL] [Abstract][Full Text] [Related]
14. Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor-induced thrombocytopenia.
Bishton MJ; Harrison SJ; Martin BP; McLaughlin N; James C; Josefsson EC; Henley KJ; Kile BT; Prince HM; Johnstone RW
Blood; 2011 Mar; 117(13):3658-68. PubMed ID: 21292776
[TBL] [Abstract][Full Text] [Related]
15. Thrombocytopenia in MDS: epidemiology, mechanisms, clinical consequences and novel therapeutic strategies.
Li W; Morrone K; Kambhampati S; Will B; Steidl U; Verma A
Leukemia; 2016 Mar; 30(3):536-44. PubMed ID: 26500138
[TBL] [Abstract][Full Text] [Related]
16. Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials.
Gavriatopoulou M; Chari A; Chen C; Bahlis N; Vogl DT; Jakubowiak A; Dingli D; Cornell RF; Hofmeister CC; Siegel D; Berdeja JG; Reece D; White D; Lentzsch S; Gasparetto C; Huff CA; Jagannath S; Baz R; Nooka AK; Richter J; Abonour R; Parker TL; Yee AJ; Moreau P; Lonial S; Tuchman S; Weisel KC; Mohty M; Choquet S; Unger TJ; Li K; Chai Y; Li L; Shah J; Shacham S; Kauffman MG; Dimopoulos MA
Leukemia; 2020 Sep; 34(9):2430-2440. PubMed ID: 32094461
[TBL] [Abstract][Full Text] [Related]
17. H2S protects against fatal myelosuppression by promoting the generation of megakaryocytes/platelets.
Liu HD; Zhang AJ; Xu JJ; Chen Y; Zhu YC
J Hematol Oncol; 2016 Feb; 9():13. PubMed ID: 26912146
[TBL] [Abstract][Full Text] [Related]
18. Milestones in understanding platelet production: a historical overview.
Kuter DJ
Br J Haematol; 2014 Apr; 165(2):248-58. PubMed ID: 24528208
[TBL] [Abstract][Full Text] [Related]
19. Tyrosyl-tRNA synthetase stimulates thrombopoietin-independent hematopoiesis accelerating recovery from thrombocytopenia.
Kanaji T; Vo MN; Kanaji S; Zarpellon A; Shapiro R; Morodomi Y; Yuzuriha A; Eto K; Belani R; Do MH; Yang XL; Ruggeri ZM; Schimmel P
Proc Natl Acad Sci U S A; 2018 Aug; 115(35):E8228-E8235. PubMed ID: 30104364
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the safety and efficacy of recombinant human thrombopoietin among severe sepsis patients with thrombocytopenia: study protocol for a randomized controlled trial.
Wu Q; Ren J; Wang G; Gu G; Hu D; Liu S; Li G; Chen J; Li R; Hong Z; Ren H; Wu X; Li Y; Yao M; Zhao Y; Li J
Trials; 2015 May; 16():220. PubMed ID: 25986785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]